| |
Latest 10 SEC filings (by transaction date) for RVNC within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 17/24 | Apr 16/24 | Jordan Erica | Direct Ownership | Common Stock | S - Open market or private sale | -2,392 | $3.80 |
Mar 19/24 | Mar 18/24 | Sjuts Dustin S | Direct Ownership | Common Stock | S - Open market or private sale | -9,211 | $5.04 |
Mar 19/24 | Mar 18/24 | Moxie Dwight | Direct Ownership | Common Stock | S - Open market or private sale | -8,125 | $5.04 |
Mar 19/24 | Mar 18/24 | Schilke Tobin | Direct Ownership | Common Stock | S - Open market or private sale | -9,361 | $5.04 |
Mar 19/24 | Mar 15/24 | Sjuts Dustin S | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -2,967 | $5.31 |
Mar 19/24 | Mar 15/24 | Moxie Dwight | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,269 | $5.31 |
Mar 19/24 | Mar 15/24 | Schilke Tobin | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,822 | $5.31 |
Mar 19/24 | Mar 15/24 | Foley Mark J | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -17,228 | $5.31 |
Mar 19/24 | Mar 15/24 | Foley Mark J | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,305 | $5.31 |
Mar 8/24 | Mar 6/24 | Foley Mark J | Direct Ownership | Common Stock | P - Open market or private purchase | 30,000 | $6.98 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for RVNC within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 17/24 | Apr 16/24 | Jordan Erica | Direct Ownership | Common Stock | S - Open market or private sale | -2,392 | $3.80 |
Mar 19/24 | Mar 18/24 | Sjuts Dustin S | Direct Ownership | Common Stock | S - Open market or private sale | -9,211 | $5.04 |
Mar 19/24 | Mar 15/24 | Sjuts Dustin S | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -2,967 | $5.31 |
Mar 19/24 | Mar 18/24 | Moxie Dwight | Direct Ownership | Common Stock | S - Open market or private sale | -8,125 | $5.04 |
Mar 19/24 | Mar 15/24 | Moxie Dwight | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,269 | $5.31 |
Mar 19/24 | Mar 18/24 | Schilke Tobin | Direct Ownership | Common Stock | S - Open market or private sale | -9,361 | $5.04 |
Mar 19/24 | Mar 15/24 | Schilke Tobin | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,822 | $5.31 |
Mar 19/24 | Mar 15/24 | Foley Mark J | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -17,228 | $5.31 |
Mar 19/24 | Mar 15/24 | Foley Mark J | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -3,305 | $5.31 |
Mar 8/24 | Mar 6/24 | Foley Mark J | Direct Ownership | Common Stock | P - Open market or private purchase | 30,000 | $6.98 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Intra-Cellular Therapies (OQ:ITCI) |
Apellis Pharmaceuticals (OQ:APLS) |
Biomarin Pharmaceutical (OQ:BMRN) |